AI assistant
XOMA Royalty Corp — Director's Dealing 2012
Mar 8, 2012
33020_dirs_2012-03-08_f95e6407-398f-4513-a5de-23a11e8542fa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: XOMA Corp (XOMA)
CIK: 0000791908
Period of Report: 2012-03-06
Reporting Person: Baker Brothers Life Sciences Capital (GP), LLC (10% Owner)
Reporting Person: BAKER FELIX (10% Owner)
Reporting Person: BAKER JULIAN (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 13606093 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Common Stock Warrant (right to buy) | $1.76 | Common Stock (6608225) | Indirect |
Footnotes
F1: In addition to Baker Brothers Life Sciences Capital (GP), LLC, this Form 3 is being filed jointly by Julian C. Baker and Felix J. Baker each of whom has the same business address as Baker Brothers Life Sciences Capital (GP), LLC and may be deemed to have a pecuniary interest in securities owned by it. Because of certain relationships with other security holders of the Issuer, the Reporting Persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (Continued in footnote 2).
F2: However, the Reporting Persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, or Rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
F3: Represents securities owned directly by Baker Brothers Life Sciences, L.P., the sole general partner of which is Baker Brothers Life Sciences Capital, L.P., a limited partnership the sole general partner of which is Baker Brothers Life Sciences Capital (GP),LLC. Julian C. Baker and Felix J. Baker are controlling members of Baker Brothers Life Sciences Capital (GP), LLC.
F4: Exercisable immediately
F5: Expiration date is 5 years from the date of Issuance
F6: Represents 13,216,449 warrant shares each of which is exercisable for .5 shares of the Issuers common stock at an exercise price of $1.76 per share.